Beyond counts: a common unit for human suffering

Official statistics tell us how many people are affected. WSI asks how much suffering those experiences may represent.

WSI combines the number of people affected, modeled severity, and duration into Universal Suffering Units (USU) - anchored to a defined six-hour kidney-stone pain reference.

The long-term goal is to make very different harms easier to compare and help decision-makers see where reducing suffering could have the greatest impact.

Current results are experimental pilot estimates with clearly stated assumptions.

3 completed pilotsInfectious disease, food insecurity, and child nutritionOne common referenceA defined six-hour kidney-stone pain trajectoryVisible assumptionsSource data and modeled inputs remain separate

What WSI could help show

Diseases, humanitarian conditions, and other harms are usually reported in different units. WSI is testing whether one intensity-time framework can make those figures easier to interpret together.

1

Compare unlike harms more consistently

Put cases, prevalence estimates, and humanitarian severity categories into the same experimental reporting format.

2

See what drives burden

Separate the effects of how many people are affected, how severe the experience may be, and how long it lasts.

3

Track change over time

Repeat the analysis as source data and mappings improve.

4

Inform where relief may matter most

Give researchers, funders, and public institutions a clearer basis for discussing priorities.

Three completed experimental USU pilot series

Each result begins with official source data and shows the assumptions used to produce the experimental estimate.

Non-ranked portfolio summary
Research seriesWhat the source reportedExperimental WSI estimateMain insightTime basis
Dengue in the Americas
WSI-DEN-AMR-2025
4.46 million suspected dengue episodes45.4 million USU
Range: 18.2-95.5 million USU
The modeled total is driven mainly by the large number of non-severe episodes; severe episodes contribute about 0.49% of central burden.Cumulative across reported episodes
Acute food insecurity
WSI-AFI-CH-2026-01
52.3 million people in Crisis or worse109 million USU/day
Range: 82.5-136 million USU/day
Phase 3 accounts for 92.1% of central modeled burden, and the country ordering remains the same as the simpler Phase 3+ source counts.One-day equivalent burden rate
Child wasting
WSI-CW-JME-2024-01
42.8 million children affected by wasting55.9 million USU/day globally
Range: 27.9-83.8 million USU/day globally
Severe wasting contributes 44.4% of central modeled daily burden despite accounting for about 28.5% of the global wasting total.One-day equivalent burden rate
These values are not a cross-series ranking. Dengue is cumulative, while food insecurity and child wasting are one-day equivalent rates. The populations, sources, coverage, and mapping maturity also differ.

From public evidence to an experimental common unit

1

Start with trusted evidence

Use cases, prevalence, people affected, or severity categories from established public sources.

2

Add severity and time

Apply visible low, central, and high assumptions for how intense the experience may be and how long it lasts.

3

Express the result in USU

Report the modeled intensity-time burden relative to the defined kidney-stone pain reference.

People or episodes×modeled severity×duration=modeled suffering burden

The current pilot standard uses a simple linear model. More detailed research assumptions are available on the Research Methodology page.

Explore the first three pilots

Published pilotP2 - evidence-informed mapping

Dengue in the Americas

Regional evidence with an Experimental Cumulative USU Pilot Estimate

45.4 million USU

Deterministic mapping range: 18.2-95.5 million USU

Source evidence: 4.46 million suspected dengue episodesTime basis: Cumulative across reported episodes
Published pilotP1 - early illustrative mapping

Acute food insecurity

Harmonized severity evidence with an Experimental Daily-Equivalent USU Pilot Estimate

109 million USU/day

Deterministic mapping range: 82.5-136 million USU/day

Source evidence: 52.3 million people in Crisis or worseTime basis: One-day equivalent burden rate
Published pilotP1 - early illustrative mapping

Child wasting

Global and regional evidence with an Experimental Daily-Equivalent USU Pilot Estimate

55.9 million USU/day globally

Deterministic mapping range: 27.9-83.8 million USU/day globally

Source evidence: 42.8 million children affected by wastingTime basis: One-day equivalent burden rate

View the full Research Series library

The USU layer can add context even when the ordering stays the same

Dengue

Adding duration and intensity creates a cumulative burden estimate, but the regional result remains driven by the very large non-severe episode count.

Food insecurity

The USU layer decomposes severity, yet the country ordering is unchanged from the Phase 3+ source indicator.

Child wasting

Severe wasting contributes disproportionately to modeled burden, even though the regional ordering remains unchanged.

A concrete reporting reference

One USU is defined as the modeled intensity-time burden of a specified six-hour kidney-stone pain trajectory.

The reference gives the unit a concrete scale. It does not prove that different experiences are already perfectly comparable, and it does not strengthen weak source data.

Learn about Universal Suffering Units

1 USUDefined six-hour kidney-stone pain reference

Clear public summaries, documented research methods

For general readers

Each series page leads with a two-minute brief, the headline result, and the main limits on interpretation.

For research readers

Full reports explain the source definitions, mappings, calculations, evidence level, and exclusions.

Current pilots use p=1, no overlap adjustment, deterministic low/central/high mappings, and mortality outside USU. Read the research methodology.

Understanding the project

1. What is WSI trying to do?

WSI is building and testing a common experimental language for human suffering. Each series starts with public source data and then adds explicit assumptions about intensity and duration. The aim is to learn when this common framework adds useful information and when simpler indicators are enough.

2. What is a Universal Suffering Unit?

A USU expresses modeled intensity-time burden relative to a specified six-hour kidney-stone pain trajectory. The reference makes the scale concrete. It does not by itself prove that different harms are fully comparable.

3. Does the kidney-stone reference prove that different harms are comparable?

No. The reference defines the reporting scale. Whether pain, hunger, fear, illness, and other experiences can be compared on that scale remains a research question. The pilot reports therefore show their assumptions and mapping maturity.

4. Are the three headline values directly comparable?

No. Dengue reports cumulative burden across reported 2025 episodes. Acute food insecurity and child wasting report one-day equivalent burden rates. The populations, sources, coverage, geography, and mapping maturity also differ. The three results form a research portfolio, not a cross-domain ranking.

5. What does the deterministic mapping range mean?

It is the span between the approved low and high mapping scenarios. It shows how the experimental result changes when the provisional intensity or duration assumptions change. It is not a statistical confidence interval and does not capture every source of uncertainty.

6. What do P1 and P2 mean?

P1 means an early illustrative mapping defined for transparent testing. P2 means the mapping is informed by relevant empirical or clinical evidence. Neither level means that the mapping has been fully calibrated or validated. Later maturity levels would require external review or direct empirical evaluation.

7. Are deaths included in USU?

No. The current pilot standard covers experienced suffering during lived time. Deaths are reported separately when the source provides a comparable mortality measure. WSI does not convert death into USU in these pilot series.

8. What would need to happen before WSI could guide major decisions?

The source data, state mappings, time basis, and comparison rules would need stronger validation. Results would also need to remain stable under reasonable alternative assumptions and show value beyond simpler indicators. The current pilots are research demonstrations, not decision rules.

9. How could WSI be used in practice?

WSI can help public-health agencies, humanitarian organizations, researchers, and funders compare documented burden within a clearly defined topic. It can support priority discussions, track changes over time, show whether population size or severity drives a result, improve public communication, and reveal where better data are needed. WSI is intended to inform judgment, not replace it.

10. What are WSI and USU for?

WSI is the applied research project. It produces focused series on diseases, humanitarian conditions, and other documented harms. USU is the experimental reporting framework used in those series: it combines the number of people or episodes, a modeled intensity, and a duration, then expresses the result relative to a defined reference episode.

11. Why use a kidney-stone episode as the 1.0 USU anchor?

Renal colic is intense, time-bounded, commonly assessed on clinical pain scales, and supported by published clinical data. WSI uses a specified six-hour renal-colic trajectory to define the reporting scale. This is a calibration convention, not a claim that kidney-stone pain is the most important form of suffering. Alternative references can be tested.

12. Why not measure pain alone?

Physical pain is one form of suffering, but serious negative experience can also involve breathlessness, nausea, fatigue, hunger, panic, fear, grief, or disruption of basic living conditions. USU is intended to represent experienced suffering more broadly. Each non-pain state still needs a clear definition, an evidence basis, and a stated mapping maturity.

13. Why not rely only on cases, deaths, or DALYs?

Case counts show how many people or episodes were reported, but they do not show how intense or prolonged the experience may have been. Death counts remain essential and are reported separately. DALYs and QALYs are established health measures with different purposes. WSI adds an experimental experienced-suffering perspective and keeps the original indicators visible beside it.

14. Why focus on one condition or event at a time?

A focused series can keep the source, definitions, time period, and model consistent across all included locations. That is cleaner than adding a different mixture of available harms for every country. Over time, many focused series can form a broader evidence library without forcing them prematurely into one total score.

15. What does each WSI series report?

Each published pilot shows the source evidence, the modeled states, the cumulative or daily-equivalent time basis, the central experimental USU estimate, the deterministic mapping range, the mapping maturity, and the main interpretation limits. Mortality is reported separately when a comparable source measure exists. Public briefs, full reports, and research methods provide different levels of detail.

16. How are total and per-capita burden different?

Total burden reflects the aggregate modeled burden in the included population. A per-capita or per-analyzed-population value reflects concentration relative to a stated denominator. The two views can produce different orderings, so WSI keeps them separate and identifies the denominator used.

17. How are intensity and duration estimated?

Each modeled state receives low, central, and high assumptions that are documented in a mapping note. P1 mappings are early illustrative assumptions; P2 mappings are informed by relevant empirical or clinical evidence. Duration is taken from the source or supporting evidence when possible. Snapshot-based series use a one-day equivalent rather than assuming that a state persisted for an entire season or year.

18. Where do the data come from?

WSI primarily uses official public-health, humanitarian, demographic, and research sources. Each series identifies its source, reporting period, geographic scope, and release version. Source data remain separate from the assumptions introduced by the WSI model.

19. What does it mean when a country is absent from a series?

Absence does not mean absence of suffering. A country may fall outside the source coverage, use an incompatible definition, have a different reporting period, or lack enough data for the stated analysis. Each series defines its source universe and explains important exclusions.

20. How does WSI handle uncertainty?

The current pilot standard uses approved low, central, and high mapping scenarios. The resulting deterministic range shows how the estimate changes under those assumptions; it is not a confidence interval. Full reports also describe source limitations and other uncertainty that the range does not capture. More advanced probabilistic analyses may be used in later studies when they add value.

21. How is psychological suffering represented?

Psychological suffering can be modeled only when the state is clearly defined and supported by credible evidence. Physical and psychological suffering are not assumed to be identical. Any mapping for anxiety, depression, grief, trauma, or fear would be context-specific and would require explicit assumptions and further validation. None of the first three pilots provides a general psychological-suffering mapping.

22. How are overlapping harms handled?

The current pilot standard does not apply an overlap adjustment. Categories within one model must be mutually exclusive or made exclusive before calculation. Separate series are not added into one country total when the same people and time periods may overlap. Future work may examine overlap when person-level evidence supports it.

23. How subjective is the method?

The source counts are observed or estimated by the source organization; the USU mapping adds judgment about intensity and sometimes duration. WSI makes those choices visible through low, central, and high scenarios, mapping-maturity labels, and source-versus-model disclosures. Readers can therefore see which conclusions come from the evidence and which depend on provisional assumptions.

24. What does WSI measure - and what remains separate?

WSI estimates modeled experienced suffering associated with the states included in a specific series. It does not measure a person's worth, dignity, rights, productivity, or overall value of life. Mortality, long-term effects, caregiver burden, and other excluded outcomes remain separate unless a future series models them explicitly.

25. How does WSI relate to DALYs, QALYs, HDI, and other indices?

DALYs and QALYs summarize health loss or health-adjusted time. HDI summarizes dimensions of human development. Other indices may combine economic, political, or security indicators. WSI asks a different question: what modeled intensity-time burden is associated with a defined condition or event? These measures can be used together because they describe different aspects of a problem.

26. Will WSI eventually publish an overall country ranking?

Possibly, but not until a broad set of series has sufficiently comparable coverage, time bases, mappings, and treatment of overlap. The immediate product is a library of focused research series. A wider country-level view would be introduced only if it becomes stable, interpretable, and more useful than showing the component series separately.

27. Could the framework be extended to non-human suffering?

The intensity-over-time structure may be relevant to animal-welfare research, but the present USU reference and WSI programme are human-centered. A non-human application would need species-specific behavioral and physiological evidence, animal-welfare expertise, and separate validation. Human and non-human estimates would not be combined by default.

28. How can researchers and organizations contribute?

WSI welcomes help with data sourcing, domain expertise, state mapping, quantitative review, replication, visualization, and critical assessment. Researchers can also test alternative assumptions, propose improved mappings, or examine whether a simpler source indicator is sufficient for a particular series.

Help test and improve the framework

Researchers, practitioners, data providers, and other interested readers are welcome to share feedback or discuss collaboration.